Literature DB >> 11686472

Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.

.   

Abstract

On October 4, 2001, CDC and state and local public health authorities reported a case of inhalational anthrax in Florida. Additional cases of anthrax subsequently have been reported from Florida and New York City. This report updates the findings of these case investigations, which indicate that infections were caused by the intentional release of Bacillus anthracis. This report also includes interim guidelines for postexposure prophylaxis for prevention of inhalational anthrax and other information to assist epidemiologists, clinicians, and laboratorians responding to intentional anthrax exposures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686472

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  46 in total

1.  Anthrax: walking the fine line between precaution and panic.

Authors:  E Weir
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

Review 2.  Laboratory safety practices associated with potential agents of biocrime or bioterrorism.

Authors:  David L Sewell
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.

Authors:  Henry S Heine; Jennifer Bassett; Lynda Miller; Bret K Purcell; W Russell Byrne
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

4.  Training for and maintaining public health surge capacity: a program for disease outbreak investigation by student volunteers.

Authors:  Eric N Gebbie; Stephen S Morse; Heather Hanson; Michael C McCollum; Vasudha Reddy; Kristine M Gebbie; Elizabeth Smailes; Sharon Balter
Journal:  Public Health Rep       Date:  2007 Jan-Feb       Impact factor: 2.792

5.  Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.

Authors:  Paul G Ambrose; Alan Forrest; William A Craig; Chistopher M Rubino; Sujata M Bhavnani; George L Drusano; Henry S Heine
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

6.  Evaluating the use of cell phone messaging for community Ebola syndromic surveillance in high risked settings in Southern Sierra Leone.

Authors:  Kangbai Jia; Koroma Mohamed
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

7.  Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Authors:  Jennifer L Williams; Stephanie S Noviello; Kevin S Griffith; Heather Wurtzel; Jennifer Hamborsky; Joseph F Perz; Ian T Williams; James L Hadler; David L Swerdlow; Renee Ridzon
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

8.  Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.

Authors:  Puneet K Dewan; Alicia M Fry; Kayla Laserson; Bruce C Tierney; Conrad P Quinn; James A Hayslett; Laura N Broyles; Andi Shane; Kevin L Winthrop; Ivan Walks; Larry Siegel; Thomas Hales; Vera A Semenova; Sandra Romero-Steiner; Cheryl Elie; Rima Khabbaz; Ali S Khan; Rana A Hajjeh; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

9.  Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.

Authors:  Carolyn M Greene; Jennita Reefhuis; Christina Tan; Anthony E Fiore; Susan Goldstein; Michael J Beach; Stephen C Redd; David Valiante; Gregory Burr; James Buehler; Robert W Pinner; Eddy Bresnitz; Beth P Bell
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Age as a risk factor for cutaneous human anthrax: evidence from Haiti, 1973-1974.

Authors:  Arnold F Kaufmann; Andrew L Dannenberg
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.